Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Pseudomonas aeruginosa 30S ribosomal subunit is the small subunit of the bacterial ribosome responsible for decoding mRNA during protein synthesis initiation. It forms the 30S initiation complex with initiation factors IF1, IF2, and IF3, where IF1 binds the A-site to block premature tRNA binding and prevent 50S subunit association until proper initiation. The subunit includes 16S rRNA and proteins like uS3 and uS13, which position mRNA and contact the 23S rRNA in the 70S ribosome. Structural features such as helix 44 (h44) serve as the primary binding site for aminoglycoside antibiotics, which induce miscoding by flipping out key nucleotides A1492/A1493. In pathogenic strains, mutations like those in uL6 alter intersubunit bridges (e.g., H69 bending), conferring aminoglycoside resistance by destabilizing ribosome assembly and reducing drug binding efficacy. This makes the 30S subunit a validated antibacterial target, though resistance via conformational changes poses therapeutic challenges. Cryo-EM studies reveal unique P. aeruginosa features, such as shorter H45/H16 helices, highlighting species-specific vulnerabilities exploitable for novel inhibitors.
Binding to helix 44 (h44) of 16S rRNA, displacing nucleotides A1492/A1493, causing miscoding, blocking intersubunit rotation, inhibiting translocation; secondary binding to helix 69 (H69) of 23S rRNA
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudomonas aeruginosa 30S ribosomal subunit (30S subunit).